Julia T. Geyer
Cornell University
PathologyOncologyImmunophenotypingImmunologyBiopsyFollicular lymphomaChronic myelomonocytic leukemiaLeukemiaMyeloid leukemiaMyeloidLymphomaBone marrowMyelofibrosisMyelodysplastic syndromesMyeloproliferative neoplasmGene rearrangementCancer researchMedicineBiologyGastroenterology
60Publications
18H-index
1,223Citations
Publications 60
Newest
#1Osvaldo Padilla (TTUHSC: Texas Tech University Health Sciences Center)H-Index: 4
#2Wayne Tam (Cornell University)H-Index: 39
Last. Julia T. Geyer (Cornell University)H-Index: 18
view all 3 authors...
Source
#1Julia T. Geyer (Cornell University)H-Index: 18
#2Sonam Prakash (UCSF: University of California, San Francisco)H-Index: 2
Last. Attilio Orazi (TTUHSC: Texas Tech University Health Sciences Center)H-Index: 56
view all 3 authors...
Abstract B-cell lymphoma of spleen may be primary (most commonly splenic diffuse large B-cell lymphoma) or secondary (typically low-grade non-Hodgkin lymphoma). Depending on the specific lymphoma subtype, there may be a predominantly white pulp pattern of involvement, a predominantly red pulp pattern or a focal nodular pattern. Splenectomy is the ideal specimen for a multiparametric integrative diagnosis of splenic lymphoma, as it allows for a combined study of morphology, immunohistology, flow ...
Source
#1Marc BraunsteinH-Index: 7
#2Kseniya Petrova-Drus (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 4
Last. Ruben Niesvizky (Cornell University)H-Index: 52
view all 13 authors...
OBJECTIVES Crystal-storing histiocytosis (CSH) is rare in plasma cell dyscrasias, with only 3 cases reported in the setting of amyloid. No cases of crystal-negative histiocytosis coincident with multiple myeloma and amyloidosis have been reported previously. METHODS A 58-year-old woman presented with pain due to destructive bone lesions and was found to have plasma cell myeloma (PCM) and marrow amyloid deposition associated with crystal-negative histiocytosis. Differential diagnoses included Lan...
Source
#1Valentina F.I. Sangiorgio (University of Milan)H-Index: 1
#2Julia T. Geyer (NewYork–Presbyterian Hospital)H-Index: 18
Last. Attilio Orazi (NewYork–Presbyterian Hospital)H-Index: 56
view all 7 authors...
Myelodysplastic syndrome (MDS) with isolated del(5q) [MDS del(5q)] is a World Health Organization (WHO)-recognized MDS entity. It is characterized by an interstitial deletion on chromosome 5q occurring either in isolation or with one additional cytogenetic abnormality, other than monosomy 7 or del(
3 CitationsSource
#1Julia T. Geyer (Cornell University)H-Index: 18
#2Elizabeth Margolskee (Cornell University)H-Index: 9
Last. Attilio Orazi (Texas Tech University Health Sciences Center at El Paso)H-Index: 56
view all 13 authors...
Development of bone marrow (BM) fibrosis and transformation to accelerated/blast phase are the main forms of disease progression in myeloproliferative neoplasms (MPN). Chronic myeloid leukemia, BCR-ABL1 -positive has several well-defined criteria that qualify for a diagnosis of accelerated phase (AP
3 CitationsSource
#1Yen-Chun Liu (University of Pittsburgh)H-Index: 2
#2Elizabeth Margolskee (Cornell University)H-Index: 9
Last. Julia T. Geyer (Cornell University)H-Index: 18
view all 9 authors...
TP53 alteration in chronic lymphocytic leukemia indicates a high-risk disease that is usually refractory to chemotherapy. It may be caused by deletion of 17p involving the loss of TP53 gene, which occurs in low percentage of patients at diagnosis but can be acquired as the disease progresses. Since patients may harbor TP53 mutation without chromosome 17p deletion, consensus recommendations call for both cytogenetic and PCR mutation analysis of TP53 in chronic lymphocytic leukemia. We conducted a...
2 CitationsSource
#1Rashmi Manur (HUP: Hospital of the University of Pennsylvania)H-Index: 1
#2Pamela J. Sung (HUP: Hospital of the University of Pennsylvania)H-Index: 5
Last. Agata M. Bogusz (HUP: Hospital of the University of Pennsylvania)H-Index: 8
view all 8 authors...
Source
#1Julia T. Geyer (NewYork–Presbyterian Hospital)H-Index: 18
#2Nuri Yigit (NewYork–Presbyterian Hospital)H-Index: 8
Last. Wayne Tam (NewYork–Presbyterian Hospital)H-Index: 39
view all 9 authors...
OBJECTIVES: Rare cases of clonally related histiocytic sarcoma (HS) following B-lymphoblastic leukemia/lymphoma (B-ALL/LBL) have been reported to date. METHODS: We present a patient with HS, which appeared as a breast mass 12 months after the initial diagnosis of B-ALL. RESULTS: Both HS and the B-ALL shared IGH-MYC and IGK gene rearrangements. Next-generation sequencing and whole-exome sequencing (WES) studies detected 35 common mutations, as well as mutations unique to B-ALL (16) and HS (15), i...
1 CitationsSource
#1Olga K. Weinberg (Boston Children's Hospital)H-Index: 20
#2Robert P. Hasserjian (Harvard University)H-Index: 48
Last. Daniel A. Arber (U of C: University of Chicago)H-Index: 53
view all 16 authors...
Acute undifferentiated leukemia is a rare type of acute leukemia that shows no evidence of differentiation along any lineage. Clinical, immunophenotypic and genetic data is limited and it is uncertain if acute undifferentiated leukemia is biologically distinct from acute myeloid leukemia with minimal differentiation, which also shows limited myeloid marker expression and has been reported to have a poor prognosis. We identified 92 cases initially diagnosed as acute undifferentiated leukemia or a...
10 CitationsSource
#1Marie Hogan (NYU: New York University)
#2Julia T. Geyer (Cornell University)H-Index: 18
Last. James B. Bussel (Cornell University)H-Index: 79
view all 3 authors...
Source